Article Menu
Need Help?
No Article Versions Notes Found
Cite
Kagedan, D.J.; Dixon, M.E.; Raju, R.S.; Li, Q.; Elmi, M.; Shin, E.; Liu, N.; El-Sedfy, A.; Paszat, L.; Kiss, A.; et al. Predictors of Adjuvant Treatment for Pancreatic Adenocarcinoma at the Population Level. Curr. Oncol. 2016, 23, 334-342. https://doi.org/10.3747/co.23.3205
Kagedan DJ, Dixon ME, Raju RS, Li Q, Elmi M, Shin E, Liu N, El-Sedfy A, Paszat L, Kiss A, et al. Predictors of Adjuvant Treatment for Pancreatic Adenocarcinoma at the Population Level. Current Oncology. 2016; 23(5):334-342. https://doi.org/10.3747/co.23.3205
Chicago/Turabian StyleKagedan, D.J., M.E. Dixon, R.S. Raju, Q. Li, M. Elmi, E. Shin, N. Liu, A. El-Sedfy, L. Paszat, A. Kiss, and et al. 2016. "Predictors of Adjuvant Treatment for Pancreatic Adenocarcinoma at the Population Level" Current Oncology 23, no. 5: 334-342. https://doi.org/10.3747/co.23.3205
APA StyleKagedan, D. J., Dixon, M. E., Raju, R. S., Li, Q., Elmi, M., Shin, E., Liu, N., El-Sedfy, A., Paszat, L., Kiss, A., Earle, C. C., Mittmann, N., & Coburn, N. G. (2016). Predictors of Adjuvant Treatment for Pancreatic Adenocarcinoma at the Population Level. Current Oncology, 23(5), 334-342. https://doi.org/10.3747/co.23.3205
